Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anthill Technologies has signed an agreement with Zafgen to apply its high-speed chemistry technologies and capabilities to Zafgen's obesity program.
Subscribe to our email newsletter
Under the agreement, Anthill will use its Acos high-speed synthesis and on-demand purification capabilities to assist Zafgen in the development of lead compounds for its obesity therapy programs.
Joseph Hogan, Jr, CEO of Anthill, said: “We are very pleased to have the opportunity to assist Zafgen in its efforts to find novel and effective therapies to combat obesity.
“We fully expect that our high-speed chemistry expertise and unique capabilities will help Zafgen to accelerate its obesity therapy discovery program.”